7 research outputs found

    Survival of Moss Reproductive Structures under Simulated Martian Environmental Conditions and Extreme Thermal Stress: Vibrational Spectroscopic Study and Astrobiological Implications

    Get PDF
    The principal goal of astrobiology is the search for extraterrestrial life forms. A key aspect is the study of the ability of different kinds of terrestrial organisms to support simulated extraterrestrial environmental conditions. Mosses are multicellular green plants, poorly studied from an astrobiological perspective. In this paper, we report experimental results obtained using two species of moss, which demonstrate that both the spores of the moss Funaria hygrometrica as well as the desiccated vegetative gametophyte shoots of the moss Tortella squarrosa (=Pleurochaete squarrosa) were capable of resisting Simulated Martian Environmental Conditions (SMEC): Mars simulated atmospheric composition 99.9% CO2, and 0.6% H2O with a pressure of 7 mbars, -73 ºC and UV irradiation of 30 mW cm-2 in a wavelength range of 200-400 nm under a limited short time of exposition of 2 hours. After being exposed to SMEC and then transferred to an appropriate growth medium, the F. hygrometrica spores germinated, producing typical gametophyte protonemal cells and leafy shoots. Likewise, detached leaves from SMEC-exposed gametophyte shoots of T. squarrosa retained the ability to produce new protonemata and shoots under suitable growth conditions. Furthermore, we studied the tolerance of these moss structures to a thermal stress of 100 °C for 1 h; in both cases the spores and shoots were capable of resisting this heat treatment. Our study using FT-Raman and FT-IR vibrational spectroscopy demonstrated that neither spores nor shoots apparently suffered significant damage in their biomolecular makeup after being subject to these stress treatments. The implications of these findings for the search of life on Mars are discussed

    Correction : Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885

    Get PDF
    The authors wish to make the following corrections to this paper [...]

    Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain : Large-Scale Epidemiological Study

    Get PDF
    (1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and 0.5 for IBD-U; 53% of patients were male and median age was 43 years (interquartile range = 31-56 years). During a median 12-month follow-up, 34% of patients were treated with systemic steroids, 25% with immunomodulators, 15% with biologics and 5.6% underwent surgery. The percentage of patients under these treatments was significantly higher in CD than UC and IBD-U. Use of systemic steroids and biologics was significantly higher in hospitals with high resources. In total, 28% of patients were hospitalized (35% CD and 22% UC patients, p < 0.01). (4) Conclusion: The incidence of IBD in Spain is rather high and similar to that reported in Northern Europe. IBD patients require substantial therapeutic resources, which are greater in CD and in hospitals with high resources, and much higher than previously reported. One third of patients are hospitalized in the first year after diagnosis and a relevant proportion undergo surgery

    Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    No full text
    corecore